SENSEION THERAPEUTICS INC — Federal Contracts, Awards & Government Contractor Profile

About SENSEION THERAPEUTICS INC

Senseion Therapeutics is a preclinical-stage pharmaceutical company developing novel therapies to treat metabolic diseases, including those associated with chloride ion-channel diseases. Their first-in-class drug candidate, SN-40X, is in development to address unmet clinical needs in metabolic disease patients.

Development of novel therapies for metabolic diseasesResearch and development of small molecule therapeuticsFocus on chloride ion-channel diseases and their complicationsInnovation in metabolic pathways and drug discovery

Is this your company?

Claim SENSEION THERAPEUTICS INC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.

Claim SENSEION THERAPEUTICS INC & see your matches

Free to claim. Takes about a minute.

Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.